iPath Series B S&P 500 VIX Mid-Term Futures ETN (NY:VXZ)
Price and Volume
Detailed Quote| Volume | 18,935 |
| Open | 57.26 |
| Bid (Size) | 55.43 (200) |
| Ask (Size) | 60.19 (100) |
| Prev. Close | 56.11 |
| Today's Range | 57.08 - 58.35 |
| 52wk Range | 51.23 - 69.33 |
| Shares Outstanding | 6,410 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Volatility Is Bottoming ↗
April 20, 2023
VIX Not Forecasting A Debt Crisis, Recession, Or Bear Market ↗
October 10, 2023
Barclays Suspends Creation Units For VXX ↗
March 15, 2022
Frequently Asked Questions
Is iPath Series B S&P 500 VIX Mid-Term Futures ETN publicly traded?
Yes, iPath Series B S&P 500 VIX Mid-Term Futures ETN is publicly traded.
What exchange does iPath Series B S&P 500 VIX Mid-Term Futures ETN trade on?
iPath Series B S&P 500 VIX Mid-Term Futures ETN trades on the New York Stock Exchange
What is the ticker symbol for iPath Series B S&P 500 VIX Mid-Term Futures ETN?
The ticker symbol for iPath Series B S&P 500 VIX Mid-Term Futures ETN is VXZ on the New York Stock Exchange
What is the current price of iPath Series B S&P 500 VIX Mid-Term Futures ETN?
The current price of iPath Series B S&P 500 VIX Mid-Term Futures ETN is 58.16
When was iPath Series B S&P 500 VIX Mid-Term Futures ETN last traded?
The last trade of iPath Series B S&P 500 VIX Mid-Term Futures ETN was at 03/06/26 08:00 PM ET
What is the market capitalization of iPath Series B S&P 500 VIX Mid-Term Futures ETN?
The market capitalization of iPath Series B S&P 500 VIX Mid-Term Futures ETN is 372.81K
How many shares of iPath Series B S&P 500 VIX Mid-Term Futures ETN are outstanding?
iPath Series B S&P 500 VIX Mid-Term Futures ETN has 373K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
